SPIA
ATNM icon

Steward Partners Investment Advisory’s Actinium Pharmaceuticals ATNM Stock Holding History

Steward Partners Investment Advisory’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.16K Hold
2,166
– – ﹤0.01% 4035
2025
Q4 		$2.95K Hold
2,166
– – ﹤0.01% 3853
2025
Q3 		$3.47K Buy
2,166
+166
+8% +$270 ﹤0.01% 3768
2025
Q2 		$2.8K Hold
2,000
– – ﹤0.01% 3660
2025
Q1 		$3.22K Hold
2,000
– – ﹤0.01% 3515
2024
Q4 		$2.52K Hold
2,000
– – ﹤0.01% 3578
2024
Q3 		$3.76K Buy
+2,000
New +$7.9K ﹤0.01% 3274
2024
Q2 		– Sell
-100
Closed -$783 – 3613
2024
Q1 		$783 Hold
100
– – ﹤0.01% 3394
2023
Q4 		$508 Hold
100
– – ﹤0.01% 3359
2023
Q3 		$592 Hold
100
– – ﹤0.01% 3240
2023
Q2 		$742 Buy
+100
New +$851 ﹤0.01% 3162
2022
Q3 		– Sell
-100
Closed – – 3225
2022
Q2 		$0 Buy
+100
New +$568 ﹤0.01% 3236

Other funds holding ATNM

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Steward Partners Investment Advisory's ATNM Position: Q1 2026 in Review

Steward Partners Investment Advisory held its Actinium Pharmaceuticals (ATNM) position steady in Q1 2026 at 2,166 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #4035.

Steward Partners Investment Advisory first reported a position in ATNM in Q2 2022 and has held it in 12 quarters since. The position peaked at $3.76K in Q3 2024. 54 funds tracked by Wall St. Rank hold ATNM as of Q1 2026.

  • Steward Partners Investment Advisory held 2,166 shares of Actinium Pharmaceuticals worth $2.16K as of Q1 2026.
  • Steward Partners Investment Advisory left its Actinium Pharmaceuticals share count unchanged in Q1 2026.
  • Actinium Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4035 holding.
  • Steward Partners Investment Advisory first reported a position in Actinium Pharmaceuticals in Q2 2022 and has held it in 12 quarters since.
  • Steward Partners Investment Advisory's Actinium Pharmaceuticals position peaked at $3.76K in Q3 2024.
  • 54 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.